Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2COVID-19 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hypogonadism 1Head and Neck Neoplasms 1HIV Infections 1Death 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

testosterone 17 beta-cypionate 1Testosterone Propionate 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methyltestosterone 1Mental Status and Dementia Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypogonadism × Practice Guidelines as Topic × 30 days × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡